2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

U.S. Dialysis Facility Characteristics Associated with Racial Disparities in Access to the Kidney Deceased Donor Transplant Waiting List.

J. Gander, L. Plantinga, S. Paul, S. Pastan, R. Patzer.
Understanding the Drivers Behind an Early Post-KAS Rise in Delayed Graft Function (DGF) Rates.

D. Stewart, A. Kucheryavaya, D. Klassen.
Understanding the Dynamics of a Suddenly Plateauing Kidney Waiting List.

A. Wilk, D. Stewart, E. Edwards.
Understanding the Initial Rise in Kidney Discard Rates Observed Post-KAS.

D. Stewart,¹ A. Kucheryavaya,¹ R. Brown,¹ D. Klassen,¹ N. Turgeon,² M. Aeder.³
Underweight BMI Is Associated with Graft Failure and Increased Mortality in Liver Transplant Recipients.

T. Alhamad,¹ N. Carlsson,² X. Liu,³ J. Wellen,⁴ J. Garonzik-Wang,⁴ S.-H. Chang.²
Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.

M. Yanik,¹ R. Mannon,² M. Seifert.¹
United States versus Australia: Is "Percentage Decline in Estimated Glomerular Filtration Rate" Truly a Surrogate Outcome in Graft Survival?

K. Parker,² A. Rice,¹ A. Kirby,¹ M. Pinion,¹ K. Parker.²
Universal Stenting of Renal Transplants Associated with a Low Complication Rate When Quality Assurance Program Ensures Stent Removal.

C. Yeast, J. Riley, C. Ashbaugh, G. Ross, M. Wakefield.
Updated Experience of Living Donor Right Hepatectomy Using Mini-Incision Technique.

S. Nagai, A. Yoshida, M. Rizzari, K. Collins, D. Kim, M. Abouljoud.
Ureteroenterostomy in Kidney Transplant: Retrospective Analysis of 30 Consecutive Cases.

H. Marinho Neto, B. Leslie, J. Neves Neto, M. Almeida, A. Pessoa, J. Offernni, M. Nogueira, S. Ximenes, W. Aguiar, H. Tedesco, J. Medina Pestana.
Urgent Kidney Transplantation as Successful Treatment of Calciphylaxis in Three Patients with End-Stage Kidney Failure.

E. Nordheim,¹ D. Dahle,¹ I. Syse,¹ A. Åsberg,^1,2 A. Reisæter,¹ H. Holdaas,¹ T. Jenssen,^1,3 A. Hartmann.^1,4
Urinary CXCL9 Protein as Biomarker for BK Polyoma Viremia.

N. Sarabu,¹ R. El-Rifai,² J. Augustine,¹ A. Padiyar,¹ A. Huml,¹ T. Young,¹ V. Rodriguez,¹ D. Hricik.¹
Urinary Exosomal Annexin A1 Is a Predictive Biomarker of Post Kidney Transplant Complications.

H. Harada,¹ T. Murakami,² C. Yamamoto,² K. Hotta,¹ N. Fukuzawa,¹ M. Mitsuhashi.²
Urinary Expression of miRNA-155, miRNA-210, miRNA-142 and CXCL-10 Production Predicts the Risk of Acute Rejection and Graft Outcome in Renal Transplant Recipients.

O. Millan,¹ K. Budde,² C. Sommerer,³ I. Aliart,¹ O. Rissling,² B. Bardaji,⁴ M. Matz,² M. Zeier,³ I. Silva,⁴ L. Guirado,⁴ M. Brunet.¹
Urinary Markers of Proximal Tubular Dysfunction in Kidney Transplant as Predictors for CKD.

P. Garcia, V. Garcia-Nieto, J. Navarro, E. Martin, A. Rivero, A. Jarque, J. Gonzalez-Posadas, M. Macia.
Urinary Neutrophil Gelatinase-Associated Lipocalin in Living Kidney Donor Nephrectomy.

Y. Yoon,¹ H. Lee,¹ D. Joo,² K. Huh,² M. Kim,² S. Kim,² Y. Kim,² W. Han.¹
Urinary Tract Infections During the First Year After Renal Transplantation: Risk Factors and Nomograms.

C. Jironda, V. López, M. Cabello, A. Duarte, C. Gutiérrez, P. Ruiz, D. Burgos, D. Hernández.
Urinary Virome in Human Kidney Transplants Reveals Multiple Virus Subtypes with Distinct Genome Polymorphisms.

R. Ranjan,¹ A. Rani,¹ H. McGee,¹ D. Brennan,² P. Finn,¹ D. Perkins.^1,3
Urine Cell-Free Supernatant Metabolites Diagnostic of Antibody Mediated Rejection in Kidney Allografts.

M. Alkadi,¹ J. Lee,¹ D. Dadhania,¹ T. Muthukumar,¹ C. Snopkowski,¹ C. Li,¹ S. Salvatore,¹ S. Seshan,¹ K. Suhre,² M. Suthanthiran.¹
Urine IP-10 as the Biomarker for ABMR in Kidney Transplant Recipient with DGF.

N. Townamchai,¹ A. Leelahavanichakul,² J. Supapol,³ S. Wattanatorn,¹ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
Urine-Derived Cell Lines as a Novel Tool for Monitoring Allo-Reactivity in Kidney Transplant Patients.

C. Thieme,¹ B. Weist,¹ M. Schmück,¹ P. Reinke,¹ N. Babel.^1,2
Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.
Use of Elderly Donors in Liver Transplantation: A Paired-Match Analysis at a Single Center.

D. Ghinolfi, Q. Lai, P. DeSimone, D. Pezzati, G. Cirillo, F. Filipponi.
Use of En-Bloc Vascularized Rectus Sheath Allograft to Achieve Abdominal Closure in Pediatric Liver and Multivisceral Transplantation.

J. Reddy, A. Rege, D. Vikraman, B. Collins, T. Brennan, S. Knechtle, D. Sudan, K. Ravindra.
Use of Integrated National Registry and Pharmacy Claims Data to Identify Diabetes Mellitus After Live Pancreas Donation.

K. Lentine,^1,7 N. Lam,² H. Randall,⁸ D. Axelrod,³ D. Segev,^4,1 G. Hess,⁵ A. Garg,⁶ D. Brennan,⁷ B. Kasiske,⁸ M. Schnitzler.^8,1
Use of Preoperative Embolization Prior to Transplant Nephrectomy.

C. Yeast, J. Riley, J. Holyoak, S. Weinstein, G. Ross, M. Wakefield.
Use of Small (<10kg) Kidney Donors in the US.

J. Smith,^1,2 J. Snyder,¹ A. Israni,¹ B. Kasiske,¹ R. Perez.³
Use of the Psychosocial Assessment Tool to Identify Risk in Families of Pediatric Liver Transplant Recipients.

E. Fredericks, T. Smith, J. Sevecke, S. Eder, C. Limke, C. Shneider, M. Lopez.
Using 3D Printing in Complex Pediatric Renal Transplantation.

P. Chandak,¹ N. Byrne,² N. Karunanithy,³ C. Callaghan,¹ I. Mushtaq,⁴ S. Marks,⁴ J. Stajonovic,¹ Z. Ahmed,¹ N. Kessaris,¹ N. Mamode.¹
Using Gastrointestinal Biopsy to Predict Outcome in Patients Evaluated for Cardiac Transplantation for Amyloidosis: A Report from the International Consortium on Cardiac Amyloidosis Transplantation (iCCAT).

Y. Li,¹ K. Verkouw,¹ S. Tabtabai,¹ R. Barrios,² R. Gill,³ J. Koo,⁴ C. Marboe,⁵ E. Rodriguez,⁶ C. Tan,⁶ T. De Marco,³ J. Estep,² M. Hanna,⁶ M. Maurer,⁵ J. Patel,⁴ V. Selby,³ M. Semigran,¹ J. Stone.¹
Using Predictive Modeling to Manage Cardiovascular Risk and Improve Kidney Transplant Outcomes.

W. Moran, J. Zhang, Z. Su, D. Taber, P. Mauldin, T. Srinivas.
Utility in Treating Renal Failure in End-Stage Liver Disease with Simultaneous Liver-Kidney Transplantation.

X. Cheng,¹ M. Stedman,¹ W. Kim,² J. Tan.¹
Utility of a Routine Bench Cholangiogram for Deceased Split Liver Procedure.

N. Battula, R. Anbarasan, V. Thumma, K. Sharif, T. Perera, P. Muiesan, D. Mirza.
Utility of a Scoring Tool for Living Kidney Donor Volunteers.

S. Lien,¹ L. Willey,² A. Lecuyer-Koich,² M. Voges,² T. Dunn.²
Utility of Six-Minute-Walk Distance in Predicting Lung Transplant Benefit in the Lung Allocation Score Era.

S. Shah,¹ D. Tumin,³ B. Whitson,² A. Pope-Harman,¹ S. Kirkby,¹ A. Kilic,² P. Lee,² D. Hayes.^1,3
Utilization and Discard of HCV+ Donor Livers in the Advent of Direct-Acting Antiviral Therapy.

M. Bowring, L. Kucirka, A. Massie, X. Luo, M. Sulkowski, D. Segev, C. Durand.
Utilization and Post-Transplant Outcomes Associated with Hepatitis C+ Donor Kidneys in the Advent of Direct-Acting Antivirals.

M. Bowring, L. Kucirka, A. Massie, X. Luo, M. Sulkowski, D. Segev, C. Durand.
Utilization of HCV-Positive Donors' Kidneys: Potential Benefits in the Era of Direct Acting Antiviral (DAA) Therapy.

B. Amundsen,¹ M. Sise,² M. Lin,³ H. Deirawan,¹ E. Heher,² B. Kimball,¹ J. Markmann,¹ N. Elias.¹
Utilization of Parenteral Nutrition in Patients Undergoing Liver Transplantation.

D. Liang,¹ S. Gordon Burroughs,¹ J. Nolte,¹ M. Boktour,¹ J. Ensor,¹ A. Ali,¹ T. Hirase,¹ J. Hall,¹ S. Spear,¹ L. Moore,¹ C. Mobley,¹ A. Saharia,¹ S. Hai,² A. Gaber,¹ R. Ghobrial.¹
Utilization of Plasmapheresis and High Dose of Immunoglobulins in the Treatment of the High Level of De Novo Donor Specific Antibodies for the Successful Islet Allotransplantation.

J. Solomina,¹ Z. Tekin,¹ S. Matosz,¹ K. Golab,¹ C. Thomas,² J. Golebiewska,³ S. Ramachandran,¹ L. Schenck,¹ W. Chon,¹ M. Tibudan,¹ N. Marek-Trzonkowska,⁴ J. Millis,¹ P. Witkowski.¹
Utilization of Subacute Rehabilitation Facility Early After Kidney Transplantation.

F. Luan, M. Ben-Israel, S. Mulgaonkar.
Utilizing HLA Single Antigen Flow Beads Assays to Evaluate Anti-MAMU Antibody in Sensitized Nonhuman Primate Model.

J. Kwun,¹ C. Burghuber,² M. Manook,¹ A. Clark,³ D. Chen,³ S. Knechtle.¹

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z